Literature DB >> 7603754

Mycoplasma hominis pneumonia in aboriginal adults.

R Norton1, L Mollison.   

Abstract

Mycoplasma hominis (M. hominis) is a well recognized extragenital pathogen. Its role as a pathogen of the respiratory tract, however, remains difficult to determine. Four cases of pneumonia are presented in which M. hominis was isolated from blood, tracheal aspirates or post-mortem lung tissue. All 4 of these isolates were in young Aboriginal adult males. M. hominis is the least fastidious of the human mycoplasmas and grows well on most blood-containing bacteriological media. The recognition and identification of M. hominis is important as it is commonly resistant to erythromycin which would be the drug of choice in most atypical pneumonias. Early recognition and treatment with tetracycline instead may influence outcome.

Entities:  

Mesh:

Year:  1995        PMID: 7603754     DOI: 10.1080/00313029500169472

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  4 in total

1.  New Diagnostic Real-Time PCR for Specific Detection of Mycoplasma hominis DNA.

Authors:  Andres Pascual; Katia Jaton; Béatrice Ninet; Jacques Bille; Gilbert Greub
Journal:  Int J Microbiol       Date:  2010-07-25

2.  Mycoplasma hominis-associated parapharyngeal abscess following acute Epstein-Barr virus infection in a previously immunocompetent adult.

Authors:  Karina J Kennedy; Sam Prince; Timothy Makeham
Journal:  J Clin Microbiol       Date:  2009-07-29       Impact factor: 5.948

3.  Mycoplasma hominis necrotizing pleuropneumonia in a previously healthy adolescent.

Authors:  Andres Pascual; Marie-Helene Perez; Katia Jaton; Gaudenz Hafen; Stefano Di Bernardo; Jacques Cotting; Gilbert Greub; Bernard Vaudaux
Journal:  BMC Infect Dis       Date:  2010-11-24       Impact factor: 3.090

4.  Mycoplasma hominis bloodstream infection and persistent pneumonia in a neurosurgery patient: a case report.

Authors:  Qiang Wang; Xiaofang Tang; Stijn van der Veen
Journal:  BMC Infect Dis       Date:  2022-02-21       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.